Showing posts with label Johnson and Johnson. Show all posts
Showing posts with label Johnson and Johnson. Show all posts

January 26, 2010

Harvard Psychiatrist and MGH Liable for Criminal Sanctions?

Do Johnson and Johnson executives and Harvard child psychiatrist Joseph Biederman need to be criminally prosecuted? In deposition, Biederman admitted soliciting J and J for money and a $350 million J and J research center at Mass General Hospital for promoting their antipsychotic Risperdal. Biederman later "tested" Risperdal on little children and put out citations (studies in various manuals) allowing for Medicaid payment for this dangerous antipsychotic for bipolar disorder in children. Medicaid fraud by all three parties and should be criminally and civilly prosecuted by the US Attorney's Office and state Attorney Generals.

The article shows that the Johnson and Johnson Center for Pediatric Psychopathology Research, a center at Massachusetts General Hospital was funded by Johnson and Johnson and headed by Harvard child psychiatrist Joseph Biederman from 2002 to 2005. Court documents show that Johnson and Johnson contributed at least $700,000 for the center.

The article also shows how Biederman was promising study results on Risperdal and Concerta to help promote the drugs. This was before he actually did the "studies." Biederman sounds like he belongs in Washington DC, where the politicians are always helping people, while they enrich themsleves on taxpayer money.

http://www.boston.com/news/local/massachusetts/articles/2009/03/21/senator_broadens_inquiry_into_psychiatrist/

US Senator broadens inquiry into psychiatrist

Suggests MGH doctor was biased in research




Joseph Biederman,

Harvard Child Psychiatrist 


By Liz Kowalczyk 
Boston  Globe Staff
March 21, 2009

January 24, 2010

US Charges Johnson and Johnson

US Charges Johnson and Johnson


In the latest case in the government's campaign against abusive drug-marketing practices, the Justice Department charged Johnson & Johnson with paying "tens of millions of dollars in kickbacks" to a nursing-home pharmacy company to boost sales of J&J drugs to nursing-home patients.

Prosecutors, in a complaint filed in federal court in Boston Friday, accused J&J of illegally paying Omnicare Inc. to buy J&J medicines and recommend their use to nursing homes. Under the arrangements, prosecutors alleged, Omnicare's annual purchases of J&J medicines nearly tripled to more than $280 million.

The drugs included the blockbuster antipsychotic Risperdal, which was prescribed to control anxiety among patients with dementia and Alzheimer's, prosecutors said, though the drug isn't specifically approved for those uses.

http://online.wsj.com/article/SB10001424052748703657604575004902853166786.html

JANUARY 16, 2010
J&J Is Accused of Kickbacks to Omnicare on Drug Sales
By JONATHAN D. ROCKOFF
Wall Street Journal

July 31, 2009

FDA Approves New Use for Invega


http://www.cnbc.com/id/32242454

FDA approves new use for antipsychotic Invega
The Associated Press
CNBC
31 Jul 2009 06:13 PM E